Skip to content

Lobbying by Imperial Tobacco Canada Limited: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Client of a consultant lobbyist

Imperial Tobacco Canada Limited

Meetings this Parliament
10
With MPs
3
Since Nov 2021
10
Active registrations
1

Most recent reported meeting: Mar 18, 2026.

Who they meet

Since the current Parliament opened.

MPs

Institutions

  • Finance Canada (FIN)5
  • House of Commons3
  • Office of the Quebec Lieutenant1
  • Justice Canada (JC)1
  • Atlantic Canada Opportunities Agency (ACOA)1

Registrations in effect

Consultant In effect since Sep 16, 2026

Consultant Yves-Alexandre Comeau of Echo Strategies

Consultant lobbyists

  • Yves-Alexandre Comeau Former designated public office holder

    Formerly Directeur des communications, Cabinet de la ministre, Santé Canada (2017–2018)

  • Yves-Alexandre Comeau Former designated public office holder

    Formerly Directeur des communications, Cabinet de la ministre, Santé Canada (2017–2018)

  • Yves-Alexandre Comeau Former designated public office holder

    Formerly Directeur des communications, Cabinet de la ministre, Santé Canada (2017–2018)

Institutions they may lobby: Atlantic Canada Opportunities Agency (ACOA), Finance Canada (FIN), House of Commons, Office of the Quebec Lieutenant, Prime Minister's Office (PMO), Public Health Agency of Canada (PHAC), Rural Economic Development (Minister’s Office)

What they're lobbying on (7)
  • 7) Identifying opportunities to engage in consultations, policy reviews, or federal programs relevant to smoking cessation or health innovation.
  • 6) Providing timely information and scientific context related to harm reduction and nicotine pouches;
  • 5) Promoting policy and regulatory approaches that support innovation in smoking cessation
  • 4) Facilitating engagement with Members of Parliament, political staff, and relevant officials at Health Canada, Finance Canada, and the Privy Council Office Targeted Public Office Holders
  • 3) discuss Zonnic as part of a broader harm reduction framework and to promote the role of regulated nicotine replacement therapies (NRTs) in helping adult smokers quit combustible tobacco.
  • 2) Support Imperial Tobacco Canada's public policy engagement strategy related to Zonnic, a nicotine pouch approved by Health Canada.
  • 1) Regulations related to nicotine replacement therapies approved by Health Canada under the Food and Drugs Act (FDA).

Registration 961747-382466-3. Look it up in the official Registry

Reported meetings

Spreadsheet

  • Reported by Yves-Alexandre Comeau · Consultant

    • Djamel Boumenna · Policy advisor, Office of the Quebec Lieutenant
    1) Regulations related to nicotine replacement therapies approved by Health Canada under the Food and Drugs Act (FDA).

    Official report

  • Reported by Yves-Alexandre Comeau · Consultant

    • ray Anjoul · Senior Advisor | Parliamentary Affairs and Atlantic Region, Justice Canada (JC)
    • keizer alexis · Regional Advisor - Atlantic | conseillère régionale - Atlantique, Atlantic Canada Opportunities Agency (ACOA)
    1) Regulations related to nicotine replacement therapies approved by Health Canada under the Food and Drugs Act (FDA).

    Official report

  • Reported by Yves-Alexandre Comeau · Consultant

    • Kyle Fox · Deputy Director of Policy, Finance Canada (FIN)
    5) Promoting policy and regulatory approaches that support innovation in smoking cessation

    Official report

  • Reported by Yves-Alexandre Comeau · Consultant

    2) Support Imperial Tobacco Canada's public policy engagement strategy related to Zonnic, a nicotine pouch approved by Health Canada.

    Official report

  • Reported by Yves-Alexandre Comeau · Consultant

    • kyle fox · Director of Policy, Finance Canada (FIN)
    3) discuss Zonnic as part of a broader harm reduction framework and to promote the role of regulated nicotine replacement therapies (NRTs) in helping adult smokers quit combustible tobacco. Read more

    1) Regulations related to nicotine replacement therapies approved by Health Canada under the Food and Drugs Act (FDA).

    Official report

  • Reported by Yves-Alexandre Comeau · Consultant

    • Kyle Fox · Deputy Director of Policy, Finance Canada (FIN)
    2) Support Imperial Tobacco Canada's public policy engagement strategy related to Zonnic, a nicotine pouch approved by Health Canada. Read more

    3) discuss Zonnic as part of a broader harm reduction framework and to promote the role of regulated nicotine replacement therapies (NRTs) in helping adult smokers quit combustible tobacco.

    1) Regulations related to nicotine replacement therapies approved by Health Canada under the Food and Drugs Act (FDA).

    Official report

  • Reported by Yves-Alexandre Comeau · Consultant

    • Ian Foucher · chef de cabinet, Finance Canada (FIN)
    5) Promoting policy and regulatory approaches that support innovation in smoking cessation

    Official report

  • Reported by Yves-Alexandre Comeau · Consultant

    • Élyse Moisan · Conseiller en politiques, Finance Canada (FIN)
    5) Promoting policy and regulatory approaches that support innovation in smoking cessation

    Official report

  • Reported by Yves-Alexandre Comeau · Consultant

    3) discuss Zonnic as part of a broader harm reduction framework and to promote the role of regulated nicotine replacement therapies (NRTs) in helping adult smokers quit combustible tobacco. Read more

    Official report

  • Reported by Yves-Alexandre Comeau · Consultant

    3) discuss Zonnic as part of a broader harm reduction framework and to promote the role of regulated nicotine replacement therapies (NRTs) in helping adult smokers quit combustible tobacco. Read more

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.